Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · IEX Real-Time Price · USD
12.64
+0.75 (6.31%)
At close: Jul 19, 2024, 4:00 PM
12.80
+0.16 (1.27%)
Pre-market: Jul 22, 2024, 7:01 AM EDT
Perspective Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for CATX stock have an average target of 22, with a low estimate of 17 and a high estimate of 30. The average target predicts an increase of 74.05% from the current stock price of 12.64.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 18, 2024.
Analyst Ratings
The average analyst rating for CATX stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 25, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 20, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $2 → $19 | Buy | Reiterates | $2 → $19 | +50.32% | Jun 18, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 18, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $30 | Buy | Reiterates | $30 | +137.34% | Jun 14, 2024 |
Financial Forecast
Revenue This Year
534.48K
from 1.43M
Decreased by -62.73%
Revenue Next Year
327.83K
from 534.48K
Decreased by -38.66%
EPS This Year
-0.10
from -1.70
EPS Next Year
-0.11
from -0.10
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1.4M | 1.5M | 1.5M | 14.8M |
| Avg | 534,480 | 327,828 | 571,537 | 14.4M |
| Low | 294,000 | n/a | n/a | 13.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -1.9% | 173.7% | 364.0% | 2,494.2% |
| Avg | -62.7% | -38.7% | 74.3% | 2,420.0% |
| Low | -79.5% | - | - | 2,321.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.07 | -0.07 | -0.08 |
| Avg | -0.10 | -0.11 | -0.11 |
| Low | -0.12 | -0.14 | -0.14 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.